Skip to main content
Top

Cellular Oncology

Issue 6/2020

Content (17 Articles)

Non-coding RNAs underlying chemoresistance in gastric cancer

Arash Poursheikhani, Zahra Bahmanpour, Ehsan Razmara, Ladan Mashouri, Mohammad Taheri, Dorsa Morshedi Rad, Hassan Yousefi, Amirreza Bitaraf, Sadegh Babashah

Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update

Pan Xie, Jun-Luan Mo, Jin-Hong Liu, Xi Li, Li-Ming Tan, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu

Open Access Metastasis Original Article

RETRACTED ARTICLE: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer

Yizhi Xiao, Side Liu, Jiaying Li, Weiyu Dai, Weimei Tang, Li Xiang, Wenjing Zhang, Jianjiao Lin, Jing Wang, Xiaosheng Wu, Guangnan Liu, Yuyang Liu, Yaying Chen, Huiqiong Zhu, Yusi Wang, Zhizhao Lin, Qiong Yang, Tianming Chen, Yong Sun, Aimin Li, Jing Xiong, Jide Wang

Open Access Breast Cancer Original paper

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways

Yang Zhang, Bingwei Xu, Junfeng Shi, Jieming Li, Xinlan Lu, Li Xu, Helen Yang, Nevean Hamad, Chi Wang, Dana Napier, Shuixiang He, Chunming Liu, Zeyi Liu, Hai Qian, Li Chen, Xiaowei Wei, Xucai Zheng, Jian-An Huang, Olivier Thibault, Rolf Craven, Dongping Wei, Yueyin Pan, Binhua P. Zhou, Yadi Wu, Xiuwei H. Yang

Neuroblastoma Original paper

Aberrantly expressed Bruton’s tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells

Narpati Wesa Pikatan, Yen-Lin Liu, Oluwaseun Adebayo Bamodu, Michael Hsiao, Wen-Ming Hsu, Sofia Mubarika Haryana, Sutaryo, Tsu-Yi Chao, Chi-Tai Yeh

Prostate Cancer Original paper

Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression

Changlin Li, Hui Sun, Wei Wei, Qiuzi Liu, Yinglei Wang, Ying Zhang, Fuming Lian, Fangchao Liu, Chenchen Li, Kaicheng Ying, Hang Huo, Zhi Qi, Benyi Li

Hepatitis B Original paper

Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation

Zhuo Yu, Hai Feng, Yunhui Zhuo, Man Li, Xiaojun Zhu, Lingying Huang, Xin Zhang, Zhenhua Zhou, Chao Zheng, Yun Jiang, Fan Le, Dae-Yeul Yu, Alfred Szelok Cheng, Xuehua Sun, Yueqiu Gao

Open Access Biomarkers Original paper

Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers

G. Mantini, A. M. Vallés, T. Y. S. Le Large, M. Capula, N. Funel, T. V. Pham, S. R. Piersma, G. Kazemier, M. F. Bijlsma, E. Giovannetti, C. R. Jimenez

Open Access Voraxapar Original paper

Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation

Cansu Tekin, Hella L Aberson, Cynthia Waasdorp, Gerrit K J Hooijer, Onno J de Boer, Frederike Dijk, Maarten F Bijlsma, C Arnold Spek

Glioblastoma Original paper

Activation of dopamine receptor D1 inhibits glioblastoma tumorigenicity by regulating autophagic activity

Kang Yang, Minghai Wei, Zhaofei Yang, Zhenfa Fu, Ruixue Xu, Cheng Cheng, Xi Chen, Sheng Chen, Eric Dammer, Weidong Le

Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia

Jorge Antonio Elias Godoy Carlos, Keli Lima, Juan Luiz Coelho-Silva, Raquel de Melo Alves-Paiva, Natália Cestari Moreno, Hugo Passos Vicari, Fábio Pires de Souza Santos, Nelson Hamerschlak, Leticia Veras Costa-Lotufo, Fabiola Traina, João Agostinho Machado-Neto

Prostate Cancer Letter to the Editor

Nomograms using a small panel of genes for predicting the diagnosis and aggressiveness of prostate cancer

Katia R. M. Leite, Fabio L. Ortega, Lucas P. Damiani, Vanessa Guimarães, Nayara Viana, Iran A. Silva, Sabrina T. Reis, Ruan Pimenta, Sanarelly P. Adonias, Cristina Chammas, Miguel Srougi, Willian Nahas

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine